Últimas noticias sobre Medpace Hldgs (NASDAQ:MEDP) Bolsa

Medpace Hldgs

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Medpace Holdings Inc

MedPeer Inc

Needham analyst Scott Berg reiterates Braze (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) with a Buy and maintains $50 price target.

News

Price Target

Reiteration

Analyst Ratings

BRZE

Needham Reiterates Buy on Braze, Maintains $50 Price Target

<a href="https://www.ea.com/news/ea-sports-realism-technology#:~:text=Welcoming%20TRACAB%20Technologies%20to%20the%20EA%20SPORTS%20family&amp;text=As%20they%20join%20EA%20SPORTS,and%20simulate%20real%2Dworld%20action.">https://www.ea.com/news/ea-sports-realism-technology#:~:text=Welcoming%20TRACAB%20Technologies%20to%20the%20EA%20SPORTS%20family&amp;text=As%20they%20join%20EA%20SPORTS,and%20simulate%20real%2Dworld%20action.</a>
&nbsp;
 At <a href="https://www.ea.com/sports">EA SPORTS</a>, we're driven by the passion and energy that sports ignite in fans around the world. This spirit is what inspires us every day to push the boundaries of what's possible, creating sports experiences that grow fandom, and bring together global communities in, around, and beyond our games.
At the core of that is a constant focus on innovation. For the last several years, EA SPORTS has invested in tools, technology and capabilities that further enhance the authenticity and immersion in our games, and enable us to move at the speed of sport. Our solutions are able to ingest massive amounts of real-world volumetric data to inform Artificial Intelligence (AI) and machine learning models, all powering incredible advancements in our gameplay and animation capabilities.&nbsp;
And today, we're taking another step to accelerate our efforts by welcoming a new team to our EA SPORTS family.

Electronic Arts Agrees To Acquire TRACAB Technologies; No Financial Terms Disclosed

Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) will be reporting its fourth-quarter earnings on Tuesday. Wall Street expects $2.13 in EPS and $96.56 billion in revenues as the company reports<a href="https://www.benzinga.com/calendars/earnings?tickers=GOOGL" target="_blank" rel="noreferrer noopener"> after market hours</a>.
The stock is up 41.10% over the past year, 7.02% YTD.
Let&#8217;s look at what the charts indicate for Alphabet stock and how the stock currently maps against Wall Street estimates.
Read Also: <a href="https://www.benzinga.com/media/25/01/43375573/mexican-president-asks-google-not-to-rename-gulf-of-mexico-takes-a-swipe-at-trump-decision-by-asking-for-mexican-america">Mexican President Asks Google Not To Rename Gulf Of Mexico, Takes A Swipe At Trump Decision By Asking For &#8216;Mexican America&#8217;</a>
<h2 class="wp-block-heading">Alphabet Stock Strongly Bullish Ahead Of Q4 Earnings</h2>
Alphabet stock is currently in a strongly bullish trend, with its share price of $202.73 comfortably above its key exponential moving averages (EMAs) for five, 20 and 50 days. This indicates solid upward momentum and suggests that the stock could continue to outperform in the near term. 
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020325&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="626" height="490" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03111813/Screenshot-2025-02-03-at-9.43.05-PM.png" alt="" class="wp-image-762948" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03111813/Screenshot-2025-02-03-at-9.43.05-PM.png 626w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03111813/Screenshot-2025-02-03-at-9.43.05-PM-300x235.png 300w" sizes="(max-width: 626px) 100vw, 626px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020325&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
Short-term bullish signals are further supported by Alphabet stock trading above its eight-day simple moving average (SMA) of $198.54, 20-day SMA of $196 and 50-day SMA of $187.86. These SMA levels confirm strong buying momentum and indicate the potential for continued upward movement. 
Additionally, Alphabet stock remains well above its 200-day SMA of $174.00, reinforcing long-term strength. 
The Moving Average Convergence Divergence (MACD) indicator is at 3.37, signaling further bullish momentum, while the Relative Strength Index (RSI) at 61.64 indicates that the stock is not yet overbought, leaving room for continued growth. 
Alphabet stock investors should consider the current trend as favorable, but also monitor for any signs of overheating or correction if RSI climbs higher.
<h2 class="wp-block-heading">Alphabet Analysts See 5% Upside</h2>
Ratings &amp; Consensus Estimates:<a href="https://www.benzinga.com/quote/GOOGL/analyst-ratings" target="_blank" rel="noreferrer noopener"> The consensus analyst rating</a> on Alphabet stock stands at a Buy currently with a price target of $210.91. The latest analyst ratings from Needham, DA Davidson and Cantor Fitzgerald suggest a 4.59% upside for Alphabet stock, with an average price target of $211.67.
GOOGL Stock Price Action: Alphabet stock was trading at $203.30 at the time of publication.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/25/01/43403758/exclusive-this-magnificent-7-stock-will-feel-the-pinch-of-feds-rate-decision-poll-shows" target="_blank" rel="noreferrer noopener">EXCLUSIVE: This &#8216;Magnificent 7&#8217; Stock Will Feel The Pinch Of Fed&#8217;s Rate Decision, Poll Shows</a></li>
</ul>
Image: Shutterstock

Technicals

Previews

Tech

Trading Ideas

GOOG

GOOGL

Alphabet Q4 Earnings Preview: Bullish Trend Just Getting Started?

Advanced Micro Devices Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) shares are experiencing some weakness Monday ahead of earnings this week. Here&#8217;s a look at what <a href="https://www.benzinga.com/markets/equities/25/01/43376506/intel-will-be-fighting-for-every-socket-in-the-data-center-business-says-co-ceo-michelle-holthaus-as-competition-from-amd-nvidia-heats-up">you need to know</a>.
What To Know: AMD is set to report fourth-quarter financial results after the market close on Tuesday. The chipmaker is expected to report earnings of $1.08 per share and revenue of $7.53 billion, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
AMD shares are facing some selling pressure on Monday alongside broader markets after U.S. President Donald Trump signed executive orders on Saturday to impose 25% tariffs on Canada and Mexico and 10% tariffs on China, which are expected to take effect on Tuesday.
AMD shares have trended lower in recent months as the U.S. has ramped up restrictions on AI chip exports due to national security concerns. AMD stock is down about 19% since the company last reported earnings.
In a new note to clients on Monday, Northland Capital analyst Gus Richard brushed off AI demand concerns and noted that the biggest cloud service providers (CSPs) are not adjusting their spending plans. 
&#8220;We believe more GPU capacity will be needed as more computing is required for post-training and RLM Interference. The risk is that enhanced export controls will impact the flow of AI chips into China,&#8221; Richard said.
&#8220;It is important to note that only the AI chips need to be smuggled. China has access to chips and the capability to build an AI cluster. They only need to smuggle in the GPUs.&#8221;
Check This Out: <a href="https://www.benzinga.com/tech/25/02/43423412/nvidia-on-deepseek-success-alibaba-unveils-advanced-ai-model-and-more-this-week-in-artificial-intelligence">Nvidia On DeepSeek Success, Alibaba Unveils Advanced AI Model And More: This Week In Artificial Intelligence</a>
Several AI-related names sold off&nbsp;last week as investors weighed the potential for Chinese startup DeepSeek to disrupt America&#8217;s AI lead. The company reportedly developed its open-source LLM in a couple of months at a much lower cost than competitors.&nbsp;
Richard also flagged recent rumors that Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) has grown frustrated with AMD. The Northland Capital analyst noted that the frustration is likely related to the company&#8217;s open-source software, which is not as well developed as Nvidia Corp&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) Cuda. 
&#8220;However, DeepSeek has just demonstrated the power of an open-source model. CSPs buy product road maps, and AMD has proven that it can take on an entrenched competitor and win in the server market. We think CSPs have good visibility in AMD&#8217;s product roadmap and are confident in their ability to execute,&#8221; Richard said. 
The Northland Capital analyst has an <a href="https://www.benzinga.com/analyst-stock-ratings">Outperform rating</a> on AMD shares with a price target of $175. 
AMD Price Action: AMD shares were down 1.67% at $114.01 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/02/43420511/palantir-ceo-alex-karp-sounds-alarm-on-chinas-deepseek-could-this-threaten-palantirs-ai-dominance">Palantir CEO Alex Karp Sounds Alarm on China&#8217;s Deepseek – Could This Threaten Palantir&#8217;s AI Dominance?</a></li>
</ul>
Photo: courtesy of AMD.

Earnings

Movers

MSFT

NVDA

AMD Reports Q4 Earnings This Week: What's Going On With The Chip Stock?

HC Wainwright &amp; Co. analyst Emily Bodnar reiterates Tenaya Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNYA#NASDAQ">TNYA</a>) with a Buy and maintains $18 price target.

TNYA

HC Wainwright & Co. Reiterates Buy on Tenaya Therapeutics, Maintains $18 Price Target

<figure class="wp-block-image size-large"><img decoding="async" src="https://thearorareport.com/wp-content/uploads/2025/02/2025-02-03_09h06_31.png" alt="" /></figure>
To gain an edge, this is what you need to know today.
<h4 class="wp-block-heading">What To Do Now</h4>
Please <a href="https://thearorareport.com/chart-analysis-stock-market-trump-tariffs-what-to-do-now-spy-mc-02032025">click here</a> for an enlarged chart of SPDR S&amp;P 500 ETF Trust (SPY) which represents the benchmark stock market index S&amp;P 500 (SPX).
Note the following:
<ul>
<li>The chart shows that in the early trade the stock market is below the micro resistance zone in the aftermath of the tariffs.</li>
<li>The chart shows the stock market is still significantly above the 200 day moving average.&nbsp; The 200 day moving average coincides with the support zone shown on the chart.</li>
<li>Stock futures have improved from where they were trading on Sunday evening.</li>
<li>President Trump's executive orders on tariffs were issued on Friday.</li>
<li>Going into Friday, Wall Street did not believe that Trump would actually impose tariffs, even though Trump had been very clearly saying for the last week that tariffs would go into effect on February 1.&nbsp; The consensus on Wall Street was that it was simply a negotiating tactic.</li>
<li>On Friday, when Trump issued an executive order imposing tariffs, at first, Wall Street was taken aback with surprise.&nbsp; Then, a story was promoted that Trump was about to rescind the tariffs.&nbsp; The story received so much publicity that the White House was forced to specifically state that the story was wrong.</li>
<li>After the White House denied the story, the stock market started falling.&nbsp; Momo gurus were able to arrest the fall by claiming it was going to be just like the tariffs Trump imposed on Columbia.&nbsp; The Arora Report previously shared with readers that the tariffs on Columbia were lifted very quickly.</li>
<li>Wall Street was in shock when the tariffs were still in place on Sunday evening.&nbsp; This led to a big drop in stock futures.</li>
<li>In The Arora Report analysis, investors need to pay attention to the details in the executive order.&nbsp; The executive order appears to be focused on drug flow into the U.S.
<ul>
<li>Our latest information is that Mexico is open to cooperating with the U.S. on drugs.&nbsp; It is conceivable that Trump and Mexico can reach an agreement related to drugs fairly quickly, which would likely result in the tariffs on Mexico being lifted.</li>
<li>Our latest information is that Canada is resisting full cooperation with the U.S. on drugs.&nbsp; The reason is that a wave of economic patriotism is sweeping Canada.&nbsp; Canadian politicians are mischaracterizing Trump's executive order as a trade war.</li>
</ul>
</li>
<li>Here are the other long term objectives Trump has from the tariffs:
<ul>
<li>Reduce the trade deficit.</li>
<li>Bring manufacturing to the U.S.</li>
<li>Bring foreign capital to the U.S.</li>
<li>Use money from tariffs to pay for income tax cuts.</li>
</ul>
</li>
<li>Here are the two main questions that will determine the course of the tariffs, and in turn, the course of the stock market.
<ul>
<li>Will Trump stick with the executive order, or will he start mingling longer term objectives with the current executive orders?</li>
<li>Will Canada and Mexico cooperate, or will they retaliate?</li>
</ul>
</li>
<li>In The Arora Report analysis, on the positive side, tariffs on China are less than expected.</li>
<li>In The Arora Report analysis, the situation is very fluid, and the best course of action is to keep a close eye on which way it goes.</li>
<li>At The Arora Report, we have been helping you look ahead.&nbsp; Our call was to take profits ahead of Trump's inauguration.&nbsp; The Arora Report repeated several times that once reality met hopium, the situation would change.&nbsp; In contrast, Wall Street largely did not take profits and clung to hopium.</li>
<li>Cash levels are low.
<ul>
<li>A vast majority of money managers are at the lowest cash level in years.</li>
<li>The momo crowd has invested more than 100% by taking margin.</li>
</ul>
</li>
<li>In contrast to the momo crowd and Wall Street, the protection band from The Arora Report looked ahead and took into account the volatility that was going to come when Trump started implementing his agenda.&nbsp; As such, there is no change in the protection band.&nbsp; However, investors need to stay alert – changes will be made to the protection band as new data comes in.&nbsp;&nbsp;</li>
<li>To help investors think, if Trump had rescinded tariffs over the weekend, the stock market would have been up over 1000 DJIA points this morning.&nbsp; As a reference, DJIA futures are down 638 as of this writing in the premarket because Wall Street got it wrong.</li>
<li>Both Wall Street and the momo crowd have great reasons to be concerned because they are prepared for only one scenario – the stock market going straight up to S&amp;P 500 levels of 6500 &#8211; 7000.&nbsp;&nbsp;&nbsp;</li>
<li>Expect blind money to flow into the stock market today and tomorrow.&nbsp; Blind money is the money that flows into the stock market on the first two days of the month without any analysis irrespective of market conditions.</li>
</ul>
<h4 class="wp-block-heading">Magnificent Seven Money Flows</h4>
In the early trade, money flows are negative in Apple Inc (AAPL), Amazon.com, Inc. (AMZN), Alphabet Inc Class C (GOOG), Meta Platforms Inc (META), Microsoft Corp (MSFT), NVIDIA Corp (NVDA), and Tesla Inc (TSLA).
In the early trade, money flows are negative in S&amp;P 500 ETF (SPY) and Invesco QQQ Trust Series 1 (QQQ).
<h4 class="wp-block-heading">Momo Crowd And Smart Money In Stocks</h4>
Investors can gain an edge by knowing money flows in SPY and QQQ.  Investors can get a bigger edge by knowing when smart money is buying stocks, gold, and oil.  The most popular ETF for gold is SPDR Gold Trust (GLD).  The most popular ETF for silver is iShares Silver Trust (SLV).  The most popular ETF for oil is United States Oil ETF (USO).
<h4 class="wp-block-heading">Bitcoin</h4>
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is seeing selling.&nbsp; Those who are still under the illusion that bitcoin is a hedge are disappointed.&nbsp; The price action in bitcoin once again shows The Arora Report's consistent call is spot on that bitcoin is not a hedge, but instead a speculative asset that is manipulated higher during risk-on periods.&nbsp;&nbsp;
<h4 class="wp-block-heading">Protection Band And What To Do Now</h4>
It is important for investors to look ahead and not in the rearview mirror.&nbsp; The proprietary protection band from The Arora Report is very popular.&nbsp; The protection band puts all of the data, all of the indicators, all of the news, all of the crosscurrents, all of the models, and all of the analysis in an analytical framework that is easily actionable by investors.
Consider continuing to hold good, very long term, existing positions. Based on individual risk preference, consider a protection band consisting of cash or Treasury bills or short-term tactical trades as well as short to medium term hedges and short term hedges. This is a good way to protect yourself and participate in the upside at the same time.
You can determine your protection bands by adding cash to hedges.&nbsp; The high band of the protection is appropriate for those who are older or conservative. The low band of the protection is appropriate for those who are younger or aggressive.&nbsp; If you do not hedge, the total cash level should be more than stated above but significantly less than cash plus hedges.
A protection band of 0% would be very bullish and would indicate full investment with 0% in cash.&nbsp; A protection band of 100% would be very bearish and would indicate a need for aggressive protection with cash and hedges or aggressive short selling.
It is worth reminding that you cannot take advantage of new upcoming opportunities if you are not holding enough cash.&nbsp; When adjusting hedge levels, consider adjusting partial stop quantities for stock positions (non ETF); consider using wider stops on remaining quantities and also allowing more room for high beta stocks.&nbsp; High beta stocks are the ones that move more than the market.
<h4 class="wp-block-heading">Traditional 60/40 Portfolio</h4>
Probability based risk reward adjusted for inflation does not favor long duration strategic bond allocation at this time.
Those who want to stick to traditional 60% allocation to stocks and 40% to bonds may consider focusing on only high quality bonds and bonds of five year duration or less.&nbsp; Those willing to bring sophistication to their investing may consider using bond ETFs as tactical positions and not strategic positions at this time.
The Arora Report is known for its accurate calls. The Arora Report correctly called the big artificial intelligence rally before anyone else, the new bull market of 2023, the bear market of 2022, new stock market highs right after the virus low in 2020, the virus drop in 2020, the DJIA rally to 30,000 when it was trading at 16,000, the start of a mega bull market in 2009, and the financial crash of 2008. Please click here to sign up for a free forever <a href="https://thearorareport.com/generate-wealth-newsletter-benzinga">Generate Wealth Newsletter</a>.

Market Summary

$BTC

What To Do Now In The Aftermath Of Tariffs – Wall Street Caught On The Wrong Side

<a href="https://support.google.com/adspolicy/answer/9841715?hl=en#:~:text=In%20order%20to%20advertise%20for,are%20eligible%20for%20LegitScript%20Certification" title="https://support.google.com/adspolicy/answer/9841715?hl=en#:~:text=In%20order%20to%20advertise%20for,are%20eligible%20for%20LegitScript%20Certification">https://support.google.com/adspolicy/answer/9841715?hl=en#:~:text=In%20order%20to%20advertise%20for,are%20eligible%20for%20LegitScript%20Certification</a>.

Global

Google Says In March, Google Ads Healthcare&Medicines Policy To Be Updated To Allow Recovery-oriented Drug&Alcohol Addiction Services Promotion In Canada; On Feb 17, Google Ads Gambling & Games Policy Philippines Country-Specifics Will Be Updated

HC Wainwright &amp; Co. analyst Emily Bodnar maintains BriaCell Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCTX#NASDAQ">BCTX</a>) with a Buy and raises the price target from $15 to $32.

BCTX

HC Wainwright & Co. Maintains Buy on BriaCell Therapeutics, Raises Price Target to $32

<h3>Gainers</h3>
<ul>
<li>Kingsoft Cloud Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) stock moved upwards by 18.4% to $14.89 during Monday's pre-market session. The market value of their outstanding shares is at $3.5 billion. </li>
<li>MagnaChip Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MX#NYSE">MX</a>) shares increased by 17.03% to $4.74. The company's market cap stands at $176.3 million. </li>
<li>Oblong (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OBLG#NASDAQ">OBLG</a>) stock increased by 6.16% to $4.48. The market value of their outstanding shares is at $5.1 million. </li>
<li>CISO Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CISO#NASDAQ">CISO</a>) stock moved upwards by 6.06% to $1.04. The market value of their outstanding shares is at $12.2 million. </li>
<li>Aurora Mobile (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JG#NASDAQ">JG</a>) shares rose 5.76% to $8.25. The market value of their outstanding shares is at $49.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) shares declined by 47.0% to $0.14 during Monday's pre-market session. The company's market cap stands at $3.0 million. </li>
<li>Vislink Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VISL#NASDAQ">VISL</a>) stock declined by 39.29% to $1.7. The company's market cap stands at $4.1 million. </li>
<li>Cloudastructure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSAI#NASDAQ">CSAI</a>) shares fell 21.3% to $20.0. The market value of their outstanding shares is at $291.8 million. </li>
<li>NAPCO Security Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSSC#NASDAQ">NSSC</a>) shares fell 18.67% to $29.85. The market value of their outstanding shares is at $1.0 billion. The company's, Q2 earnings came out today. </li>
<li>Climb Global Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLMB#NASDAQ">CLMB</a>) shares decreased by 18.07% to $103.83. The company's market cap stands at $478.3 million. </li>
<li>Foxx Development Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXX#NASDAQ">FOXX</a>) shares fell 14.43% to $5.34. The company's market cap stands at $38.8 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CISO

CLMB

CSAI

FOXX

NSSC

OBLG

VISL

11 Information Technology Stocks Moving In Monday's Pre-Market Session

Cloudflare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>) shares are trading lower on Monday. The company introduced a one-click solution for content creators and publishers to<a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43433586/cloudflare-launches-one-click-content-credentials-to-track-image-authenticity-and-preserve-creator" rel="noreferrer noopener"> preserve an image&#8217;s digital history</a>.
The feature, based on C2PA standards, attaches a &#8220;Content Credentials&#8221; label to images, enabling creators to receive credit and consumers to verify authenticity.
Notably, Cloudflare Images users can now enable &#8220;Preserve Content Credentials&#8221; with a single click, ensuring secure metadata remains intact across Cloudflare&#8217;s global network.
Viewers can verify an image&#8217;s history using Adobe&#8217;s Content Authenticity Inspect tool. With this update, Cloudflare is expanding the adoption of content provenance and authenticity standards at scale.
Cloudflare also joined Adobe&#8217;s Content Authenticity Initiative to support broader adoption of this standard.
Andy Parsons, Senior Director Content Authenticity at Adobe, said, &#8220;Ensuring these credentials are always available at the edge provides valuable &#8216;trust signals,&#8217; ensuring those who interact with content online have confidence in what they engage with, especially with the rise of generative AI and deepfakes.&#8221;
&#8220;Cloudflare helps strengthen the integrity of digital content, supporting content authenticity for news organizations and journalists, while also enabling creators to maintain proper attribution.&#8221;
Cloudflare will report fourth-quarter results on Thursday, <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">February 6, 2025</a>.
Investors can gain exposure to the stock via&nbsp;TrueShares Technology, AI &amp; Deep Learning ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRNZ#NYSE">LRNZ</a>) and, Spear Alpha ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRX#NASDAQ">SPRX</a>).
Price Action: NET shares are down 1.77% at $135.95 at the last check Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/01/42931987/cathie-woods-ark-invest-loads-up-on-intellia-therapeutics-which-laid-off-over-a-quarter-of-its-workforce" target="_blank" rel="noreferrer noopener">Cathie Wood&#8217;s Ark Invest Loads Up On Intellia Therapeutics Which Laid Off Over A Quarter Of Its Workforce</a></li>
</ul>
Photo via T. Schneider/Shutterstock.com.

Equities

Large Cap

LRNZ

SPRX

Cloudflare Introduces One-Click Tool To Combat Image Deepfakes And Misinformation

RBC Capital analyst Drew McReynolds reiterates Rogers Communications (TSX:<a class="ticker" href="https://www.benzinga.com/stock/RCI#TSX">RCI</a>) with a Outperform and maintains C$57 price target.

TSX:RCI

TSX:RCI/B

RBC Capital Reiterates Outperform on Rogers Communications, Maintains C$57 Price Target

Meta Platforms Says Expanding GenAI Transparency For Meta's Ads Products

Investors with a lot of money to spend have taken a bearish stance on DoorDash (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with DASH, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 13 uncommon options trades for DoorDash.
This isn't normal.
The overall sentiment of these big-money traders is split between 30% bullish and 46%, bearish.
Out of all of the special options we uncovered, 9 are puts, for a total amount of $294,568, and 4 are calls, for a total amount of $798,220.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $125.0 to $220.0 for DoorDash over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
In today's trading context, the average open interest for options of DoorDash stands at 346.4, with a total volume reaching 1,515.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in DoorDash, situated within the strike price corridor from $125.0 to $220.0, throughout the last 30 days.
<h3>DoorDash Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738602058_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DASH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$7.9</td>
<td>$7.4</td>
<td>$7.49</td>
<td>$220.00</td>
<td>$564.0K</td>
<td align="right">344</td>
<td align="right">0</td>
</tr>
<tr>
<td>DASH</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$26.35</td>
<td>$25.0</td>
<td>$25.8</td>
<td>$190.00</td>
<td>$154.8K</td>
<td align="right">536</td>
<td align="right">60</td>
</tr>
<tr>
<td>DASH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$6.8</td>
<td>$6.65</td>
<td>$6.8</td>
<td>$200.00</td>
<td>$46.9K</td>
<td align="right">569</td>
<td align="right">83</td>
</tr>
<tr>
<td>DASH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$17.85</td>
<td>$17.3</td>
<td>$17.45</td>
<td>$180.00</td>
<td>$38.3K</td>
<td align="right">49</td>
<td align="right">38</td>
</tr>
<tr>
<td>DASH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$17.75</td>
<td>$17.2</td>
<td>$17.6</td>
<td>$180.00</td>
<td>$35.2K</td>
<td align="right">49</td>
<td align="right">342</td>
</tr>
</tbody>
</table>

<h3>About DoorDash</h3>
Founded in 2013 and headquartered in San Francisco, DoorDash is an online delivery demand aggregator. Consumers can use its app to order food items on-demand for delivery or in-store from merchants. Through the acquisition of Wolt in 2022, the firm also provides this service in Europe and Asia. DoorDash creates a marketplace for merchants to establish a presence online, market their offerings, and meet demand through delivery. The firm provides similar service to nonrestaurant businesses, such as grocery, retail, and pet supplies. Dash is also rolling out nascent technology like drone delivery in an effort to continually innovate and provide the best possible service to supply-side and demand-side contingents of its marketplace.
After a thorough review of the options trading surrounding DoorDash, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of DoorDash</h3>
<ul>
<li>With a trading volume of 857,143, the price of DASH is down by -1.16%, reaching $186.64.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 8 days from now.</li>
</ul>
<h3>Expert Opinions on DoorDash</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $199.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on DoorDash, which currently sits at a price target of $200. 
&#x2A; An analyst from Wells Fargo persists with their Equal-Weight rating on DoorDash, maintaining a target price of $166. 
&#x2A; An analyst from Keybanc persists with their Overweight rating on DoorDash, maintaining a target price of $225. 
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Buy rating for DoorDash, targeting a price of $205. 
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Neutral rating for DoorDash, targeting a price of $200. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for DoorDash, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

DASH

Unpacking the Latest Options Trading Trends in DoorDash

Whales with a lot of money to spend have taken a noticeably bearish stance on Netflix.
Looking at options history for Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) we detected 69 trades.
If we consider the specifics of each trade, it is accurate to state that 34% of the investors opened trades with bullish expectations and 44% with bearish.
From the overall spotted trades, 17 are puts, for a total amount of $693,138 and 52, calls, for a total amount of $3,512,079.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $600.0 to $1260.0 for Netflix over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Netflix's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Netflix's substantial trades, within a strike price spectrum from $600.0 to $1260.0 over the preceding 30 days.
<h3>Netflix Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738602053_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NFLX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$92.0</td>
<td>$91.1</td>
<td>$92.0</td>
<td>$970.00</td>
<td>$598.0K</td>
<td align="right">338</td>
<td align="right">147</td>
</tr>
<tr>
<td>NFLX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$34.1</td>
<td>$33.9</td>
<td>$34.1</td>
<td>$1120.00</td>
<td>$187.5K</td>
<td align="right">251</td>
<td align="right">57</td>
</tr>
<tr>
<td>NFLX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/07/25</td>
<td>$51.75</td>
<td>$48.5</td>
<td>$50.85</td>
<td>$925.00</td>
<td>$157.1K</td>
<td align="right">50</td>
<td align="right">47</td>
</tr>
<tr>
<td>NFLX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/14/25</td>
<td>$10.9</td>
<td>$10.2</td>
<td>$10.55</td>
<td>$950.00</td>
<td>$98.1K</td>
<td align="right">327</td>
<td align="right">203</td>
</tr>
<tr>
<td>NFLX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/14/25</td>
<td>$43.35</td>
<td>$42.75</td>
<td>$43.35</td>
<td>$945.00</td>
<td>$86.7K</td>
<td align="right">27</td>
<td align="right">84</td>
</tr>
</tbody>
</table>

<h3>About Netflix</h3>
Netflix's relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with more than 300 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided a regular slate of live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm introduced ad-supported subscription plans in 2022, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.
In light of the recent options history for Netflix, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Netflix's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 1,638,270, the NFLX's price is up by 0.34%, now at $980.07. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 73 days.</li>
</ul>
<h3>Professional Analyst Ratings for Netflix</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $989.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from B of A Securities persists with their Buy rating on Netflix, maintaining a target price of $1175. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Underweight rating on Netflix with a target price of $715. 
&#x2A; Consistent in their evaluation, an analyst from Macquarie keeps a Outperform rating on Netflix with a target price of $1150. 
&#x2A; Consistent in their evaluation, an analyst from Guggenheim keeps a Buy rating on Netflix with a target price of $950. 
&#x2A; An analyst from Seaport Global upgraded its action to Buy with a price target of $955. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Netflix, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

NFLX

What the Options Market Tells Us About Netflix

Whales with a lot of money to spend have taken a noticeably bullish stance on DraftKings.
Looking at options history for DraftKings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DKNG#NASDAQ">DKNG</a>) we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 62% of the investors opened trades with bullish expectations and 37% with bearish.
From the overall spotted trades, 4 are puts, for a total amount of $266,632 and 4, calls, for a total amount of $195,434.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $40.0 to $46.0 for DraftKings over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for DraftKings options trades today is 779.14 with a total volume of 2,303.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for DraftKings's big money trades within a strike price range of $40.0 to $46.0 over the last 30 days.
<h3>DraftKings Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738602047_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DKNG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$6.45</td>
<td>$6.35</td>
<td>$6.35</td>
<td>$44.00</td>
<td>$150.5K</td>
<td>197</td>
<td>251</td>
</tr>
<tr>
<td>DKNG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$4.3</td>
<td>$4.2</td>
<td>$4.2</td>
<td>$46.00</td>
<td>$74.7K</td>
<td>270</td>
<td>178</td>
</tr>
<tr>
<td>DKNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$8.65</td>
<td>$7.9</td>
<td>$8.65</td>
<td>$40.00</td>
<td>$51.9K</td>
<td>552</td>
<td>0</td>
</tr>
<tr>
<td>DKNG</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$3.85</td>
<td>$3.8</td>
<td>$3.8</td>
<td>$43.00</td>
<td>$51.6K</td>
<td>1.0K</td>
<td>137</td>
</tr>
<tr>
<td>DKNG</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/07/25</td>
<td>$0.73</td>
<td>$0.72</td>
<td>$0.72</td>
<td>$42.50</td>
<td>$43.5K</td>
<td>1.6K</td>
<td>1.0K</td>
</tr>
</tbody>
</table>

<h3>About DraftKings</h3>
DraftKings got its start in 2012 as an innovator in daily fantasy sports. Then, following a Supreme Court ruling in 2018 that allowed states to legalize online sports wagering, the company expanded into online sports and casino gambling, where it generally holds the number two or three revenue share position across states in which it competes. DraftKings is now live with online or retail sports betting in about 30 states and iGaming in seven states, with both products available to around 40% of Canada's population. The company also operates a non-fungible token commissioned-based marketplace and develops and licenses online gaming products.
<h3>Present Market Standing of DraftKings</h3>
<ul>
<li>Currently trading with a volume of 2,616,877, the DKNG's price is down by -0.17%, now at $41.88. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 10 days.</li>
</ul>
<h3>Professional Analyst Ratings for DraftKings</h3>
3 market experts have recently issued ratings for this stock, with a consensus target price of $49.333333333333336.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Susquehanna continues to hold a Positive rating for DraftKings, targeting a price of $54. 
&#x2A; Maintaining their stance, an analyst from JMP Securities continues to hold a Market Outperform rating for DraftKings, targeting a price of $50. 
&#x2A; An analyst from Benchmark has revised its rating downward to Buy, adjusting the price target to $44. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest DraftKings options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

DKNG

Decoding DraftKings's Options Activity: What's the Big Picture?

Susquehanna analyst Joseph Stauff maintains Melco Resorts and Enter (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLCO#NASDAQ">MLCO</a>) with a Positive and lowers the price target from $10 to $9.

Melco Resorts & Entertainment Limited - American Depositary Shares

MLCO

Susquehanna Maintains Positive on Melco Resorts and Enter, Lowers Price Target to $9

PayPal Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) will be reporting fourth-quarter earnings on Tuesday. Wall Street expects $1.12 in EPS and $8.26 billion in revenues as the company reports<a href="https://www.benzinga.com/calendars/earnings?tickers=PYPL" target="_blank" rel="noreferrer noopener"> before market hours</a>.
The stock is up 42.22% over the past year, 1.55% YTD.
Let&#8217;s look at what the charts indicate for PayPal stock and how the stock currently maps against Wall Street estimates.
Read Also: <a href="https://www.benzinga.com/trading-ideas/25/01/43175684/the-future-of-finance-3-fintech-stocks-set-to-take-wall-street-by-storm-in-2025">The Future of Finance: 3 Fintech Stocks Set to Take Wall Street by Storm in 2025</a>
<h2 class="wp-block-heading">PayPal Stock Strongly Bearish Ahead Of Q4 Earnings</h2>
PayPal stock is in a strongly bearish trend, with its share price of $87.64 trading below key exponential moving averages (EMAs) of five-day, 20-day and 50-day periods. This suggests continued selling pressure and an increased risk of further bearish movement. However, some technical indicators provide a more mixed outlook.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020325&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="626" height="490" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03104642/Screenshot-2025-02-03-at-9.16.30-PM.png" alt="" class="wp-image-762872" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03104642/Screenshot-2025-02-03-at-9.16.30-PM.png 626w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/03104642/Screenshot-2025-02-03-at-9.16.30-PM-300x235.png 300w" sizes="(max-width: 626px) 100vw, 626px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020325&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
PayPal stock remains below its eight-day simple moving average (SMA) of $88.98, 20-day SMA of $88.47 and 50-day SMA of $87.93, signaling short-term weakness. The long-term trend, however, remains supportive, with PayPal stock well above its 200-day SMA of $73.72, reinforcing overall strength.
Momentum indicators show a neutral-to-bullish setup. The Moving Average Convergence Divergence (MACD) at 0.40 supports potential bullish movement, though the Relative Strength Index (RSI) at 48.00 suggests the stock is neither overbought nor oversold. 
PayPal stock investors should watch for a sustained move above key moving averages to confirm a shift toward bullish momentum or further downside if selling pressure persists.
<h2 class="wp-block-heading">PayPal Analysts See Limited Upside</h2>
Ratings &amp; Consensus Estimates:<a href="https://www.benzinga.com/quote/PYPL/analyst-ratings" target="_blank" rel="noreferrer noopener"> The consensus analyst rating</a> on PayPal stock stands at an Outperform currently with a price target of $90.30. Recent analyst ratings from Piper Sandler, Wells Fargo and Citigroup imply a 3.34% upside for PayPal stock with a $90 target.
PYPL Stock Price Action: PayPal stock was trading at $87.64 at the time of publication.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/02/43437906/constellation-brands-most-exposed-name-as-trump-tariffs-go-live-analysts-advise-adjusting-prices">Constellation Brands &#8216;Most Exposed Name&#8217; As Trump Tariffs Go Live: Analysts Advise Adjusting Prices</a></li>
</ul>
Image: Shutterstock

Fintech news covering the emerging Financial Technology services sector

Fintech

PYPL

PayPal Stock In Danger Of Post-Earnings Dive? Q4 Preview Shows Risk

AstraZeneca Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>) has abandoned plans for a $554.32 million (450 million pounds) vaccine manufacturing facility in the U.K. following disagreements with government officials over state support, marking a setback for Prime Minister Sir Keir Starmer's administration.
In August 2024, AstraZeneca reconsidered its planned investment in a new vaccine-manufacturing site, a departure from CEO&nbsp;Pascal Soriot's previous statement that the company was "absolutely ready to go."
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/01/43273643/fda-approves-astrazeneca-daiichi-sankyos-enhertu-for-certain-type-of-breast-cancer-patients" rel="noreferrer noopener">FDA Approves AstraZeneca, Daiichi Sankyo's Enhertu For Certain Type Of Breast Cancer Patients</a>
The U.K. Treasury, under the direction of&nbsp;Rachel Reeves, is reportedly considering decreasing government support for AstraZeneca by <a target="_blank" href="https://www.benzinga.com/general/biotech/24/08/40526625/astrazeneca-threatens-to-move-vaccine-production-amid-reduced-state-support" rel="noreferrer noopener">over 20 million pounds</a>.
As a result, AstraZeneca said it might relocate the project from Speke in Merseyside, U.K., to France.
According to the Financial Times <a target="_blank" href="https://www.ft.com/content/c38f3342-7842-4c3a-876a-3a4403bed1a2" rel="noreferrer noopener">report</a> citing sources familiar with the matter, the pharmaceutical giant rejected a revised offer of 78 million pounds in financial aid after months of negotiations.
The U.K. government initially planned to provide around 90 million pounds in support under the previous Conservative administration, including 70 million pounds in grants and 20 million pounds for research and development.
However, after Labour took office last summer, officials reviewed AstraZeneca's proposed R&amp;D investment and concluded it was lower than expected.
As a result, the government reduced its support package to 40 pounds million. Although a later offer raised this figure to 78 million pounds, AstraZeneca ultimately turned it down.
The Financial Times <a target="_blank" href="https://www.ft.com/content/c38f3342-7842-4c3a-876a-3a4403bed1a2" rel="noreferrer noopener">report</a> adds that AstraZeneca also raised broader concerns about the UK's pharmaceutical environment during discussions about the Liverpool-based plant.
These included the NHS's rejection of its breast cancer drug Enhertu and the health service's approach to drug pricing, sources said.
One individual close to AstraZeneca described the industry's relationship with U.K. officials as "toxic," arguing that the country now has one of the least favorable commercial environments for pharmaceuticals in the Western world.
AstraZeneca recently announced a plan to invest C$820 million ($570 million)&nbsp;in Canada, creating&nbsp;more than 700 jobs <a target="_blank" href="https://www.benzinga.com/general/biotech/25/01/43190131/astrazeneca-to-pump-570-million-into-canada-driving-expansion-job-growth" rel="noreferrer noopener">across all business areas</a>.
The&nbsp;investment&nbsp;will support the move to a larger, state-of-the-art office facility in the <a target="_blank" href="https://www.benzinga.com/topic/canada" rel="noreferrer noopener">greater Toronto area</a>.
Price Action: At last check on Monday, AZN stock was down 0.56% to $70.37.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43429620/triumph-group-reaches-3b-acquisition-deal-with-private-equity-investors" target="_blank" rel="noreferrer noopener">Triumph Group Agrees To Go Private In $3 Billion Acquisition Deal; Stock Jumps</a></li>
</ul>
Image by Robert Way via Shutterstock

Biotech

Government

Health Care

Media

General

AstraZeneca Blames 'Toxic' Climate As It Walks Away from Over $550 Million UK Vaccine Plant

Susquehanna analyst Charles Minervino maintains Baker Hughes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>) with a Positive and raises the price target from $53 to $55.

Susquehanna Maintains Positive on Baker Hughes, Raises Price Target to $55

<a href="https://x.com/wsteaks/status/1886454081377435857" title="https://x.com/wsteaks/status/1886454081377435857">https://x.com/wsteaks/status/1886454081377435857</a>

Macro Economic Events

Politics

Economics

ABC News Reporter Will Steakin Posts On X "SoS Marco Rubio has been made acting administrator of USAID, multiple sources tell ABC News"

Miller-Howard Small Cap Dividend Q3 2024 Commentary

LVS Advisory Q4 2024 Letter

Medpace: What Earnings Growth Rate Could Justify The Valuation?

The Ithaka Group Q4 2024 Commentary

Vulcan Value Partners Q4 2024 Letter

AMID: Multi-Factor Mid-Cap ETF With Encouraging Results

MoneyShow's Best Investment Ideas For 2025: Part 6

Baird raised the firm's price target on Medpace (MEDP) to $362 from $354 and keeps a Neutral rating on the shares. The firm preiovewed its Q4 resul...

Medpace price target raised to $362 from $354 at Baird

Giverny Capital Asset Management Q4 2024 Letter

A Quest That Has Translated Into New Investments

AAPL

ACIW

ADBE

ADMA

ALGN

ALLY

ALSN

AMID

AMKR

AMZN

ANET

ARMK

ASHTF

ASHTY

ASML

BBMC

BLDR

CACC

CHRD

CIEN

CMPGF

CMPGY

CNOB

CNOBP

CNSWF

COHR

CPRT

CRCQW

CTAS

ERFSF

FBIN

FELE

FERG

FICO

FIVE

FLQM

FTNT

GRPM

GTBIF

HEINY

HINKF

HSTM

HWKN

ICHGF

IDCC

JHMM

KLIC

KNSL

LPLA

LULU

MEDP

MELI

MIDD

MOVAA

NMRK

OASPW

PDRDF

PGNY

PGPHF

PLTR

PRBZF

PRNDY

PTON

QRVO

QVMM

RKLIF

SCHW

SDTHF

SDXAY

SDXOF

SLVM

SMRT

TSLA

UAMY

UBER

VCCTF

VCTR

WLLAW

WLLBW

Press Releases

MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Medpace Holdings, Inc. and Encourages Investors to Contact the Firm

MEDP Investigation:  Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medpace Holdings, Inc. - MEDP

Legal

MEDP Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm

MEDPACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Medpace Holdings, Inc. on Behalf of Medpace Stockholders and Encourages Investors to Contact the Firm

MEDP Investigation Reminder:  Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm

MEDP Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm

Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 10, 2025

Agilent Technologies

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Comments

Medpace Hldgs

Noticias

Últimas noticias sobre Medpace Hldgs (NASDAQ:MEDP) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL